市场调查报告书
商品编码
1287302
手术机器人市场 - 按组件、按应用、按终端用户及预测,2023 - 2032年Surgical Robots Market - By Component, By Application, By End-user & Forecast, 2023 - 2032 |
由于医疗部门对手术机器人的采用不断增加,2023-2032年期间,手术机器人市场将显著增长。随着技术的逐步发展,对手术机器人的需求也将大幅增长。越来越多的医护人员和病人选择机器人手术,不顾任何恐惧,将积极影响市场的增长。根据可靠的报告,2020年在美国进行的机器人手术超过87万例。
总的来说,手术机器人行业在组件、应用、终端用途和地区方面进行了细分。
基于组件,机器人系统部分可能会在2032年之前占到相当大的收益。可观的收入份额可归功于对微创外科手术的需求上升。这些系统拥有以最精确的方式执行关键程序的能力。高精确度、低术后并发症风险、低误差和较少的恢复时间是在未来几年增加采用这种技术的一些关键优势。
按应用划分,2032年,泌尿外科领域将增长超过45亿美元。对机器人泌尿外科手术的需求大幅上升,特别是在欧洲和亚太地区,将有助于该领域的发展。患有泌尿系统疾病的病人越来越多,将推动产品的采用率。
考虑到最终用途,医院部分预计将在2023-2032年期间表现出强劲增长。越来越多的外科手术,以及大量的住院病人,将成为推动市场增长的一个关键因素。此外,医院环境中熟练的人员和先进的医院基础设施的可用性将推动业务扩张。
从地域上看,欧洲手术机器人行业在2022年的价值超过12亿美元。由于该地区的外科手术数量不断增加,加上该地区越来越多地采用机器人辅助手术,估计该地区将录得健康增长。欧洲泌尿外科协会和其他组织已经推出了一些活动,促进了市场的增长。此外,疝气手术、全膝关节置换术、髋关节置换术和白内障手术等手术治疗的增加,预计将推动欧洲的市场扩张。
Surgical Robots Market will grow notably during 2023-2032 owing to the rising adoption of surgical robots in the healthcare sector. With the technology gradually evolving, the demand for surgical robots is slated to grow tremendously. Increasing robotic surgeries opted by healthcare professionals as well as by patients, regardless of any fear, will positively influence the market growth. As per credible reports, more than 870,000 robotic surgeries were performed in 2020 in the United States.
Overall, the surgical robot industry is segmented in terms of component, application, end-use and region.
Based on components, the robot systems segment is likely to account for considerable gains through 2032. The substantial revenue share can be credited to the rising demand for minimally invasive surgical procedures. These systems hold the capability of performing critical procedures with utmost precision. High accuracy, low risk of postoperative complications, low errors, and lesser recovery time are some of the key benefits slated to increase the adoption of this technology in the coming years.
By application, the urologic surgery segment will grow at more than USD 4.5 billion in 2032. Significantly rising demand for robotic urologic surgeries, especially in regions such as Europe and Asia Pacific, will help the segment to grow. The increasing number of patients suffering from urological disorders will fuel the product adoption rate.
Considering the end-use, the hospitals segment is anticipated to demonstrate robust growth during 2023-2032. The increasing number of surgical procedures, along with a large number of inpatient visits, will serve as a key factor driving the market growth. Besides, the availability of skilled personnel and state-of-the-art hospital infrastructure in a hospital setting will push the business expansion.
Geographically, the Europe surgical robot industry was valued at over USD 1.2 billion in 2022. The region is estimated to record healthy growth owing to the budding number of surgical procedures coupled with the increasing adoption of robotically assisted surgeries in the region. The European Association of Urology and other organizations have launched several activities contributing to the market growth. Additionally, a rise in surgical treatments such as hernia operations, complete knee replacements, hip replacements, and cataract operations is expected to fuel market expansion in Europe.